Mark Smith

Company: Finch Therapeutics
Job title: CEO
Seminars:
Industry Leaders Panel Discussion 9:00 am
• What have been the most exciting developments within the past 12 months? • What does the path of approval and the commercialization of these products look like? • If C.difficle and consortia-based therapeutics was the low-hanging fruit, what is the next area of microbiome research? • How can the focus be turned to incorporating…Read more
day: Day One